Form 4: Pulse Biosciences CEO Acquires and Disposes of Shares and Warrants
SEC Form 4 Filing
Pulse Biosciences CEO, Barrett Burke Thomas, reports acquiring and disposing of common stock and warrants at a price of $11 on July 19, 2024.
Summary
- On July 19, 2024, Barrett Burke Thomas, the President and CEO of Pulse Biosciences, Inc., engaged in transactions involving the company's securities.
- Thomas acquired 543 shares of common stock at $11 per share.
- Simultaneously, Thomas disposed of 543 shares of common stock.
- Following these transactions, Thomas directly owns 12,172 shares of Pulse Biosciences common stock.
- Thomas also acquired 543 warrants (rights to buy) with an exercise price of $11, exercisable from July 3, 2024, and expiring on July 3, 2029.
- Following these transactions, Thomas directly owns 0 warrants.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the CEO's stock and warrant activity.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings to gauge management's sentiment about the company's prospects.
Stakeholder Impact
- The transactions may be of interest to shareholders as they provide insight into the CEO's investment activity in the company.
Key Dates
| Date | Description |
|---|---|
| 07/03/2024 | Date warrants become exercisable |
| 07/19/2024 | Date of stock and warrant transactions |
| 07/03/2029 | Expiration date of warrants |
| 07/22/2024 | Date of signature on the form |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.